Cargando…

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis

INTRODUCTION: Systemic inflammation is associated with prognosis in solid tumors. The neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various stress stimuli. Studies have shown correlation of NLR to outcomes in immune checkpoint blockade, peripheral neutrophil cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sacdalan, Danielle Benedict, Lucero, Josephine Anne, Sacdalan, Dennis Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827677/ https://www.ncbi.nlm.nih.gov/pubmed/29503570 http://dx.doi.org/10.2147/OTT.S153290

Ejemplares similares

What Will Keep Me Coming Back to the Clinic: Factors Identified by Filipino Colorectal Cancer Patients Seen at a National Academic Referral Center
por: Sacdalan, Danielle Benedict, et al.
Publicado: (2019)

The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development
por: Sacdalan, Danielle Benedict, et al.
Publicado: (2021)

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)

Clinicopathologic Factors Associated with Mismatch Repair Status Among Filipino Patients with Young-Onset Colorectal Cancer
por: Sacdalan, Dennis Lee, et al.
Publicado: (2021)

Empathy
por: Sacdalan, Danielle Benedict
Publicado: (2021)

Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis
por: Vergara, John Paulo, et al.
Publicado: (2019)

Patterns of Biomarker Use in Cancer Treatment Among Medical Oncologists in the Philippines
por: Catedral, Lance Isidore, et al.
Publicado: (2020)

Treatment Outcomes of Patients With Colorectal Cancer Enrolled in a Comprehensive Benefits Program of the National Insurance System in the Philippines: Data From the Pilot Site
por: Ting, Frederic Ivan L., et al.
Publicado: (2020)

Prognostic value of neutrophil to lymphocyte ratio in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
por: Zhang, Siheng, et al.
Publicado: (2023)

Prognostic values of baseline cortisol levels and neutrophil to lymphocyte ratio in COVID-19
por: Erturk, Sengel Buket, et al.
Publicado: (2023)

Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study
por: Nasu, Izumi, et al.
Publicado: (2023)

Prognostic and predictive impact of neutrophil‐to‐lymphocyte ratio and HLA‐I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy
por: Wang, Lin, et al.
Publicado: (2022)

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy
por: Jeyakumar, Ghayathri, et al.
Publicado: (2017)

Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers
por: Thompson, Daniel, et al.
Publicado: (2021)

Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
por: Koh, C-H, et al.
Publicado: (2015)

Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer
por: Kotha, Nikhil V, et al.
Publicado: (2021)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
por: Wang, Jing-Houng, et al.
Publicado: (2022)

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
por: Drobni, Zsofia D., et al.
Publicado: (2020)

Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
por: Yang, Tao, et al.
Publicado: (2021)

Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors
por: Chen, Shixue, et al.
Publicado: (2021)

The role of the medical oncologist in the holistic care of patients with cancer in the Philippines
por: Ting, Frederic Ivan, et al.
Publicado: (2021)

Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio
por: Riff, Arnaud, et al.
Publicado: (2023)

Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy
por: Jia, Wangqiang, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
por: Bongiovanni, Alberto, et al.
Publicado: (2021)

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Zhuang, Tony Z, et al.
Publicado: (2022)

Choosing Wisely Philippines: ten low-value or harmful practices that should be avoided in cancer care
por: Ting, Frederic Ivan, et al.
Publicado: (2022)

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
por: Valero, Cristina, et al.
Publicado: (2021)

Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021)

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors
por: Calo, Corinne A., et al.
Publicado: (2022)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
por: He, Chaobin, et al.
Publicado: (2019)

Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma
por: Manatakis, Dimitrios K., et al.
Publicado: (2017)

Treatment of cancer patients during the COVID-19 pandemic in the Philippines
por: Ting, Frederic Ivan, et al.
Publicado: (2020)

Updated general recommendations in cancer management during the COVID-19 pandemic in the Philippines
por: Ting, Frederic Ivan, et al.
Publicado: (2020)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma
por: Yapar, Aliekber, et al.
Publicado: (2021)

Medical oncology care amidst the COVID-19 pandemic at the National University Hospital in the Philippines
por: Mendoza, Marvin Jonne L, et al.
Publicado: (2020)

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma
por: Wang, Junli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ftnslef4fgq6fbnk53addo89fb